{"transactions":[{"id":1508654,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-05-20T20:05:37.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":17615,"price":6.47,"value":113969.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $6.46 to $6.56 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range."}],"balance_after":777345,"source":{"system":"sec-edgar","filing":"0001104659-24-063562","document":"tm2414961-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465924063562/tm2414961-5_4seq1.xml","form_type":"4"}},{"id":1886567,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-18T20:33:38.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":10775,"price":18.05,"value":194488.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.25. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":794960,"source":{"system":"sec-edgar","filing":"0001104659-23-062375","document":"tm2316199-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465923062375/tm2316199-6_4seq1.xml","form_type":"4"}},{"id":1927105,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T20:01:29.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-23-041723","document":"tm2311410-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465923041723/tm2311410-5_4seq1.xml","form_type":"4"}},{"id":1927104,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T20:01:29.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":805735,"source":{"system":"sec-edgar","filing":"0001104659-23-041723","document":"tm2311410-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465923041723/tm2311410-5_4seq1.xml","form_type":"4"}},{"id":2265326,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-18T19:04:24.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":6324,"price":14.59,"value":92267.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.58 to $14.59. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":765735,"source":{"system":"sec-edgar","filing":"0001104659-22-062611","document":"tm2215879-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465922062611/tm2215879-8_4seq1.xml","form_type":"4"}},{"id":2303752,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-05T16:14:17.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":39375,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001104659-22-042760","document":"tm2211665-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465922042760/tm2211665-7_4seq1.xml","form_type":"4"}},{"id":2303751,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-04-05T16:14:17.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":772059,"source":{"system":"sec-edgar","filing":"0001104659-22-042760","document":"tm2211665-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465922042760/tm2211665-7_4seq1.xml","form_type":"4"}},{"id":2538916,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-19T21:01:32.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":12711,"price":29.58,"value":375991.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.32 to $29.96. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 745,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 323,448 of which are exercisable as of the date hereof."}],"balance_after":745809,"source":{"system":"sec-edgar","filing":"0001104659-21-127727","document":"tm2130435-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921127727/tm2130435-1_4seq1.xml","form_type":"4"}},{"id":2538915,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-19T21:01:32.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":15089,"price":30.31,"value":457347.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.97 to $30.69. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":758520,"source":{"system":"sec-edgar","filing":"0001104659-21-127727","document":"tm2130435-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921127727/tm2130435-1_4seq1.xml","form_type":"4"}},{"id":2538914,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-19T21:01:32.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":2200,"price":31.16,"value":68552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $31.72. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":773609,"source":{"system":"sec-edgar","filing":"0001104659-21-127727","document":"tm2130435-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921127727/tm2130435-1_4seq1.xml","form_type":"4"}},{"id":2565262,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-09-17T21:11:58.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":30000,"price":31.23,"value":936900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.77. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 775,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 315,211 of which are exercisable as of the date hereof."}],"balance_after":775809,"source":{"system":"sec-edgar","filing":"0001104659-21-117070","document":"tm2127933-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921117070/tm2127933-1_4seq1.xml","form_type":"4"}},{"id":2597436,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-08-18T21:00:39.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":2700,"price":29.27,"value":79029.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $29.39. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 805,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 309,057 of which are exercisable as of the date hereof."}],"balance_after":805809,"source":{"system":"sec-edgar","filing":"0001104659-21-107453","document":"tm2125440-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921107453/tm2125440-1_4seq1.xml","form_type":"4"}},{"id":2597435,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-08-18T21:00:39.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":27300,"price":30,"value":819000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.42 to $30.39. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":808509,"source":{"system":"sec-edgar","filing":"0001104659-21-107453","document":"tm2125440-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921107453/tm2125440-1_4seq1.xml","form_type":"4"}},{"id":2631737,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-16T21:03:08.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":30000,"price":32.02,"value":960600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 835,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 299,790 of which are exercisable as of the date hereof."}],"balance_after":835809,"source":{"system":"sec-edgar","filing":"0001104659-21-093195","document":"tm2122438-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921093195/tm2122438-1_4seq1.xml","form_type":"4"}},{"id":2665756,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-06-16T21:47:29.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":12200,"price":34.53,"value":421266.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.29 to $34.75. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 865,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 290,523 of which are exercisable as of the date hereof."}],"balance_after":865809,"source":{"system":"sec-edgar","filing":"0001104659-21-082229","document":"tm2119957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921082229/tm2119957-1_4seq1.xml","form_type":"4"}},{"id":2665755,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-06-16T21:47:29.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":17800,"price":33.8,"value":601640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.29 to $34.27. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":878009,"source":{"system":"sec-edgar","filing":"0001104659-21-082229","document":"tm2119957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921082229/tm2119957-1_4seq1.xml","form_type":"4"}},{"id":2744820,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-19T18:35:59.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":2700,"price":29.98,"value":80946.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.76 to $30.17. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 895,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 274,077 of which are exercisable as of the date hereof."}],"balance_after":895809,"source":{"system":"sec-edgar","filing":"0001104659-21-052071","document":"tm2113387-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921052071/tm2113387-1_4seq1.xml","form_type":"4"}},{"id":2744819,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-19T18:35:59.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":27300,"price":30.69,"value":837837.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.22 to $31.19. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":898509,"source":{"system":"sec-edgar","filing":"0001104659-21-052071","document":"tm2113387-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921052071/tm2113387-1_4seq1.xml","form_type":"4"}},{"id":2757114,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-05T20:17:07.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":58925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":58925,"derivative":{"exercise_price":31.58,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":58925},"source":{"system":"sec-edgar","filing":"0001104659-21-046727","document":"tm2112099-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921046727/tm2112099-9_4seq1.xml","form_type":"4"}},{"id":2757113,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-05T20:17:07.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":39285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":925809,"source":{"system":"sec-edgar","filing":"0001104659-21-046727","document":"tm2112099-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921046727/tm2112099-9_4seq1.xml","form_type":"4"}},{"id":2781327,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-17T21:07:24.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":100,"price":32.67,"value":3267.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 886,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 236,023 of which are exercisable as of the date hereof."}],"balance_after":886524,"source":{"system":"sec-edgar","filing":"0001104659-21-037933","document":"tm219986-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921037933/tm219986-1_4seq1.xml","form_type":"4"}},{"id":2781326,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-17T21:07:24.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":18518,"price":33.22,"value":615167.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.69 to $33.67. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":886624,"source":{"system":"sec-edgar","filing":"0001104659-21-037933","document":"tm219986-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921037933/tm219986-1_4seq1.xml","form_type":"4"}},{"id":2781325,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-17T21:07:24.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":11382,"price":34.06,"value":387670.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.68 to $34.67. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":905142,"source":{"system":"sec-edgar","filing":"0001104659-21-037933","document":"tm219986-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921037933/tm219986-1_4seq1.xml","form_type":"4"}},{"id":2849148,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-18T17:58:43.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":11380,"price":35.84,"value":407859.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.18 to $36.12. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 916,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 229,189 of which are exercisable as of the date hereof."}],"balance_after":916524,"source":{"system":"sec-edgar","filing":"0001104659-21-025336","document":"tm217197-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921025336/tm217197-1_4seq1.xml","form_type":"4"}},{"id":2849147,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-18T17:58:43.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":18620,"price":36.61,"value":681678.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.13 to $37.12. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":927904,"source":{"system":"sec-edgar","filing":"0001104659-21-025336","document":"tm217197-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921025336/tm217197-1_4seq1.xml","form_type":"4"}},{"id":2904001,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:47:02.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":7157,"price":42.38,"value":303313.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $42.83. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 946,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 224,438 of which are exercisable as of the date hereof."}],"balance_after":946524,"source":{"system":"sec-edgar","filing":"0001104659-21-005568","document":"tm213368-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921005568/tm213368-4_4seq1.xml","form_type":"4"}},{"id":2904000,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:47:02.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":700,"price":43.25,"value":30275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.86. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":953681,"source":{"system":"sec-edgar","filing":"0001104659-21-005568","document":"tm213368-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921005568/tm213368-4_4seq1.xml","form_type":"4"}},{"id":2903999,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:47:02.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":12396,"price":43.07,"value":533895.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.62 to $43.39. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":954381,"source":{"system":"sec-edgar","filing":"0001104659-21-005568","document":"tm213368-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921005568/tm213368-4_4seq1.xml","form_type":"4"}},{"id":2903998,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:47:02.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":7547,"price":43.8,"value":330558.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $44.41. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":966777,"source":{"system":"sec-edgar","filing":"0001104659-21-005568","document":"tm213368-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921005568/tm213368-4_4seq1.xml","form_type":"4"}},{"id":2903997,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:47:02.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2200,"price":45.01,"value":99022.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.75 to $45.50. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":974324,"source":{"system":"sec-edgar","filing":"0001104659-21-005568","document":"tm213368-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465921005568/tm213368-4_4seq1.xml","form_type":"4"}},{"id":2948211,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:04.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":1000,"price":41.97,"value":41970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.28 to $41.65. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 976,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 215,521 of which are exercisable as of the date hereof."}],"balance_after":976524,"source":{"system":"sec-edgar","filing":"0001104659-20-134932","document":"tm2038101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920134932/tm2038101-3_4seq1.xml","form_type":"4"}},{"id":2948210,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:04.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":13750,"price":43.1,"value":592625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.37 to $42.48. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":977524,"source":{"system":"sec-edgar","filing":"0001104659-20-134932","document":"tm2038101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920134932/tm2038101-3_4seq1.xml","form_type":"4"}},{"id":2948209,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:04.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":7058,"price":43.9,"value":309846.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.37 to $43.39. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":991274,"source":{"system":"sec-edgar","filing":"0001104659-20-134932","document":"tm2038101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920134932/tm2038101-3_4seq1.xml","form_type":"4"}},{"id":2948208,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:04.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":7492,"price":44.83,"value":335866.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.38 to $44.40. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":998332,"source":{"system":"sec-edgar","filing":"0001104659-20-134932","document":"tm2038101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920134932/tm2038101-3_4seq1.xml","form_type":"4"}},{"id":2948207,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:04.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":700,"price":45.82,"value":32074.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.47 to $45.56. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1005824,"source":{"system":"sec-edgar","filing":"0001104659-20-134932","document":"tm2038101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920134932/tm2038101-3_4seq1.xml","form_type":"4"}},{"id":2974625,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-18T20:00:29.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":3759,"price":44.41,"value":166937.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,006,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 208,687 of which are exercisable as of the date hereof."}],"balance_after":1006524,"source":{"system":"sec-edgar","filing":"0001104659-20-126992","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920126992/a4.xml","form_type":"4"}},{"id":2974624,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-18T20:00:29.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":10941,"price":45.04,"value":492782.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.63 to $44.64. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1010283,"source":{"system":"sec-edgar","filing":"0001104659-20-126992","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920126992/a4.xml","form_type":"4"}},{"id":2974623,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-18T20:00:29.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":300,"price":46.43,"value":13929.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.73 to $46.09. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1021224,"source":{"system":"sec-edgar","filing":"0001104659-20-126992","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920126992/a4.xml","form_type":"4"}},{"id":3027928,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-17T16:25:39.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":1529,"price":24.83,"value":37965.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.70 to $25.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,021,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 195,019 of which are exercisable as of the date hereof."}],"balance_after":1021524,"source":{"system":"sec-edgar","filing":"0001104659-20-106117","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920106117/a4.xml","form_type":"4"}},{"id":3027927,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-17T16:25:39.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":10271,"price":24.11,"value":247633.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $24.67."}],"balance_after":1023053,"source":{"system":"sec-edgar","filing":"0001104659-20-106117","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920106117/a4.xml","form_type":"4"}},{"id":3027926,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-17T16:25:39.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":3200,"price":23.09,"value":73888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.60 to $23.57."}],"balance_after":1033324,"source":{"system":"sec-edgar","filing":"0001104659-20-106117","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920106117/a4.xml","form_type":"4"}},{"id":3053634,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-18T17:15:19.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":5964,"price":23.19,"value":138305.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.07 to $23.27."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,036,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 188,185 of which are exercisable as of the date hereof."}],"balance_after":1036524,"source":{"system":"sec-edgar","filing":"0001104659-20-096575","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920096575/a4.xml","form_type":"4"}},{"id":3053633,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-18T17:15:19.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":9036,"price":23.6,"value":213249.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.29 to $24.28."}],"balance_after":1042488,"source":{"system":"sec-edgar","filing":"0001104659-20-096575","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920096575/a4.xml","form_type":"4"}},{"id":3185886,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-02T16:34:48.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":116550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on April 1, 2021, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":116550,"derivative":{"exercise_price":9.78,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":116550},"source":{"system":"sec-edgar","filing":"0001104659-20-042511","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465920042511/a4.xml","form_type":"4"}},{"id":3376195,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-08T21:16:40.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":11250,"price":17,"value":191250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,051,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof."}],"balance_after":1051524,"source":{"system":"sec-edgar","filing":"0001104659-19-061832","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919061832/a4.xml","form_type":"4"}},{"id":3376194,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-08T21:16:40.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":11250,"price":17.02,"value":191475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":1062774,"source":{"system":"sec-edgar","filing":"0001104659-19-061832","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919061832/a4.xml","form_type":"4"}},{"id":3378525,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-06T19:37:58.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":11250,"price":17,"value":191250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,074,024 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof."}],"balance_after":1074024,"source":{"system":"sec-edgar","filing":"0001104659-19-060674","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919060674/a4.xml","form_type":"4"}},{"id":3378524,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-06T19:37:58.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":11250,"price":17.052,"value":191835.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":1085274,"source":{"system":"sec-edgar","filing":"0001104659-19-060674","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919060674/a4.xml","form_type":"4"}},{"id":3381797,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-04T16:15:50.000Z","date":"2019-10-31","kind":"sale","acquired":false,"shares":11250,"price":17,"value":191250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,096,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof."}],"balance_after":1096524,"source":{"system":"sec-edgar","filing":"0001104659-19-059505","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919059505/a4.xml","form_type":"4"}},{"id":3406191,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-09-25T16:31:13.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":11250,"price":17.05,"value":191812.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,107,774 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 106,870 of which are exercisable as of the date hereof."}],"balance_after":1107774,"source":{"system":"sec-edgar","filing":"0001104659-19-051354","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919051354/a4.xml","form_type":"4"}},{"id":3563952,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-03T17:36:38.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":78900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on April 1, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":78900,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":78900},"source":{"system":"sec-edgar","filing":"0001104659-19-019724","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465919019724/a4.xml","form_type":"4"}},{"id":3860710,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90812,"kind":"person","name":"Love Colin","position":1,"cik":"0001376493","reported_name":"Love Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-26T17:23:02.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":15,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-18-047451","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376493/000110465918047451/a4.xml","form_type":"4"}}]}